VASCELLARI, SARAH
 Distribuzione geografica
Continente #
EU - Europa 108.741
NA - Nord America 2.821
AS - Asia 642
SA - Sud America 41
AF - Africa 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 112.262
Nazione #
IT - Italia 107.794
US - Stati Uniti d'America 2.809
CN - Cina 361
SE - Svezia 254
UA - Ucraina 224
SG - Singapore 171
DE - Germania 165
GB - Regno Unito 83
FI - Finlandia 66
FR - Francia 61
VN - Vietnam 28
BR - Brasile 26
KR - Corea 24
IN - India 22
RU - Federazione Russa 15
NL - Olanda 14
AT - Austria 10
CZ - Repubblica Ceca 10
CA - Canada 9
LK - Sri Lanka 9
AR - Argentina 6
BE - Belgio 6
ES - Italia 6
IE - Irlanda 6
PT - Portogallo 6
PL - Polonia 5
IR - Iran 4
AL - Albania 3
AU - Australia 3
CL - Cile 3
CO - Colombia 3
MA - Marocco 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
JP - Giappone 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MU - Mauritius 2
NG - Nigeria 2
RO - Romania 2
TR - Turchia 2
AM - Armenia 1
BD - Bangladesh 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MX - Messico 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 112.262
Città #
Cagliari 105.179
Uta 2.194
Fairfield 325
Woodbridge 319
Chandler 237
Nyköping 194
Ashburn 191
Boardman 165
Houston 157
Jacksonville 134
Ann Arbor 128
Dearborn 121
Wilmington 118
Seattle 116
Cambridge 107
Singapore 106
Shanghai 80
Santa Clara 62
Nanjing 47
Beijing 45
Boston 43
Rome 41
Helsinki 36
New York 36
Milan 32
Dong Ket 28
Redwood City 23
Seoul 20
Nanchang 19
San Diego 18
Jiaxing 17
Los Angeles 17
Shenyang 14
Verona 14
Jinan 12
Augusta 11
Norwalk 11
San Vittore 11
Brno 9
London 9
Mountain View 9
Orange 9
Oristano 9
Phoenix 9
Zhengzhou 9
Hebei 8
Shenzhen 8
Washington 8
Cabras 7
Changsha 7
Hefei 7
Toronto 7
Vienna 7
Bobigny 6
Brussels 6
Dublin 6
Guangzhou 6
Mumbai 6
Paris 6
Rochester 6
Sassari 6
Tianjin 6
Villacidro 6
Borås 5
Kandy 5
Kunming 5
Leawood 5
San Mateo 5
Wuhan 5
Aberdeen 4
Alghero 4
Ardabil 4
Auburn Hills 4
Carpi 4
Colombo 4
Nuremberg 4
Pune 4
Sestu 4
Atlanta 3
Baltimore 3
Bari 3
Buffalo 3
Detroit 3
Edinburgh 3
Fuzhou 3
Hangzhou 3
Mascalucia 3
Medellín 3
Monserrato 3
Munich 3
Naples 3
Povoa da Galega 3
San Giovanni in Persiceto 3
Santiago 3
Simi Valley 3
Taizhou 3
Tirana 3
Yiwu 3
Aachen 2
Almaty 2
Totale 110.740
Nome #
1H NMR brain metabonomics of scrapie exposed sheep 3.927
Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4) 3.869
Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes 3.600
Novel coumarins and related copper complexes with biological activity: DNA binding, molecular docking and in vitro antiproliferative activity 3.579
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.136
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC 3.109
null 3.087
Platinum complexes with 1,10-phenanthroline derivatives: synthesis, kinetics and in vitro cytotoxicity. 3.020
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 2.944
Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells 2.917
ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep 2.623
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin 2.589
RT-QuIC detection of PrPsCJD spiked into human urine 2.527
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.524
Antiproliferative and antiviral activity of methanolic extracts from Sardinian Maltese Mushroom (Cynomorium coccineum L.) 2.514
Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study 2.260
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains 2.254
Cholesterol homeostasis and prion misfolding: a comparative study in mouse neuroblastoma cells and in sheep brains and skin fibroblasts 2.215
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.214
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.192
Distinct signatures of the gut microbiome in an Italian cohort of patients with Parkinson’s Disease 2.090
Dynamics of TT virus infection in a cohort of HCV-infected patients achieving sustained virologic responce after treatment with direct-acting antivirals 2.077
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.028
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. XII Congresso Federazione Italiana Scienze della Vita (FISV). Universita` La Sapienza Roma (Italia), 24-27 Settembre 2012. 2.011
Studies on role of cholesterol in the pathogenesis of prion disorders 2.008
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. 2.005
Gut microbiome signatures, clinical phenotypes and drugs in Parkinson’s disease 2.004
Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients 1.953
New generation QuIC assays for prion seeding activity 1.949
Synthesis, protonation constants and biological activity determination of amino acid–salicylaldehyde-derived Schiff bases 1.905
RT-QuIC detection of PrPsCJD spiked into human urine 1.882
RT-QuIC assay for the in vivo detection of PrPsCJD from the cerebrospinal fluid of CJD-suspected cases at early clinical stage of disease 1.867
null 1.848
Visualization of Prion Protein Trafficking in Primary Neurons. 1.757
PrP knockout cells expressing transmembrane PrP resist prion infection 1.673
null 1.664
Synthesis, structural characterization, formation constants and in vitro cytotoxicity of phenanthroline and imidazolidine-2-thione copper(II) complexes 1.639
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.585
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains. 1.453
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. 11o Congresso Nazionale della Societa` Italiana di Virologia, Palazzo del Capitano del Popolo, Orvieto (TR, Italia) 17-19 Settembre 2012. 1.446
Transmembrane anchoring of the prion protein in a Prnp knockout cell line: the effects of plasma membrane subdomain location on PrPres propagationE 1.374
Ultrasensitive detection of prion seeding activity by RT-QuIC and eQuIC assays for early diagnosis of prion diseases. 15° Convegno degli Istituti Zooprofilattici Sperimentali sulle Encefalopatie Spongiformi Animali, Sala Conferenze Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d’Aosta, Torino (Italia), 4-5 Ottobre 2012. 1.365
null 1.288
null 1.142
null 1.133
null 1.112
Neurodegenerative diseases and protein misfolding: new inhibitors and novel targets 1.052
Gut microbiota markers associated with obesity and overweight in Italian adults 886
Clinical phenotypes of Parkinson’s disease associate with distinct gut microbiota and metabolome enterotypes 844
Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel 784
Prions and Prion Diseases: Quaking-induced conversion (QuIC) assays for the detection and diagnosis of TSE prion diseases. 711
null 682
Parkinson’s disease: A prionopathy? 602
Synthesis, structural characterisation, complex formation constants and in vitro cytotoxicity of some copper(II) complexes 600
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 571
Studies on the role of cholesterol in the pathogenesis of prion disorders 557
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 555
Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies 514
Antimicrobial effectiveness of ozonated olive and sunflower seeds oils 483
Anti-prion activity of cholesterol esterification modulators: a comparative study in ex vivo sheep fibroblasts and lymphocytes and in mouse neuroblastoma cell lines 446
Syntesis, Structural Characterisation, Formation Constants and in vitro cytotoxicity of phenantroline and imidazoli dine-2-thione copper (II) complexs. JIB 10-0534 406
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 339
Physico-Chemical Investigation and Antimicrobial Efficacy of Ozonated Oils: The Case Study of Commercial Ozonated Olive and Sunflower Seed Refined Oils 329
Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines 317
Ionic liquids as a new effective antimicrobial approach 308
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 134
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 9
Totale 112.487
Categoria #
all - tutte 131.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.528 0 0 0 0 0 0 0 0 271 452 268 537
2020/202129.584 709 1.023 941 8.707 5.794 3.281 1.747 1.868 921 1.976 1.707 910
2021/20227.028 749 610 476 414 660 463 389 358 543 713 800 853
2022/20239.944 798 1.097 1.187 868 813 1.069 535 686 668 772 956 495
2023/20249.020 403 337 367 479 839 1.483 1.599 684 488 673 778 890
2024/202513.424 2.500 3.414 2.185 1.925 885 987 1.329 96 103 0 0 0
Totale 112.487